[go: up one dir, main page]

EP0677063A4 - NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS. - Google Patents

NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS.

Info

Publication number
EP0677063A4
EP0677063A4 EP93924934A EP93924934A EP0677063A4 EP 0677063 A4 EP0677063 A4 EP 0677063A4 EP 93924934 A EP93924934 A EP 93924934A EP 93924934 A EP93924934 A EP 93924934A EP 0677063 A4 EP0677063 A4 EP 0677063A4
Authority
EP
European Patent Office
Prior art keywords
rptpases
ligands
new class
structural domains
domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93924934A
Other languages
German (de)
English (en)
Other versions
EP0677063A1 (fr
Inventor
Joseph Schlessinger
Gilad Barnea
Martin H Grumet
Richard U Margolis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University Langone Medical Center
Original Assignee
New York University Langone Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University Langone Medical Center filed Critical New York University Langone Medical Center
Publication of EP0677063A1 publication Critical patent/EP0677063A1/fr
Publication of EP0677063A4 publication Critical patent/EP0677063A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725Proteoglycans, e.g. aggreccan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
EP93924934A 1992-10-15 1993-10-14 NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS. Withdrawn EP0677063A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96123592A 1992-10-15 1992-10-15
PCT/US1993/009838 WO1994009037A1 (fr) 1992-10-15 1993-10-14 NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS
US961235 1997-10-30

Publications (2)

Publication Number Publication Date
EP0677063A1 EP0677063A1 (fr) 1995-10-18
EP0677063A4 true EP0677063A4 (fr) 1997-05-21

Family

ID=25504220

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93924934A Withdrawn EP0677063A4 (fr) 1992-10-15 1993-10-14 NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS.

Country Status (6)

Country Link
EP (1) EP0677063A4 (fr)
JP (1) JPH08502487A (fr)
AU (1) AU5443394A (fr)
CA (1) CA2147167A1 (fr)
NZ (1) NZ257713A (fr)
WO (1) WO1994009037A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108994B2 (en) 1990-07-11 2006-09-19 New York University Receptor-type phosphotyrosine phosphatase-alpha
US6682905B1 (en) 1990-07-11 2004-01-27 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5604094A (en) * 1990-07-11 1997-02-18 New York University Receptor-type phosphotyrosine phosphatase-β
US5766922A (en) * 1995-05-26 1998-06-16 Sugen, Inc. Functional ligands for the axonal cell rcognition molecule contactin
AU3371099A (en) * 1998-03-30 1999-10-18 President And Fellows Of Harvard College Regulation of glycosaminoglycan synthesis, methods and reagents related thereto
AU2019269628A1 (en) * 2018-05-17 2020-12-03 The Board Of Trustees Of The Leland Stanford Junior University Receptor inhibition by phosphatase recruitment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2087008A1 (fr) * 1990-07-11 1992-01-12 Joseph Schlessinger Phosphotyrosine-phosphatase de recepteur

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
G. BARNEA ET AL.: "Identification of a carbonic anhydrase-like domain in the extracellular region of RPTPgamma defines a new subfamily of receptor tyrosine phosphatases", MOLECULAR AND CELLULAR BIOLOGY, vol. 13, no. 3, March 1993 (1993-03-01), WASHINGTON US, pages 1497 - 1506, XP000645723 *
J.B. LEVY ET AL.: "The cloning of a receptor-type Protein Tyrosine Phosphatase expressed in the central nervous system", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 14, 15 May 1993 (1993-05-15), MD US, pages 10573 - 10581, XP002027169 *
MARTIN GRUMET ET AL.: "Functional characterization of Chondroitin Sulfate Proteoglycans of brain: Interactions with neurons and neural cell adhesion molecules", THE JOURNAL OF CELL BIOLOGY, vol. 120, no. 3, February 1993 (1993-02-01), pages 815 - 824, XP000645732 *
NEIL X. KRUEGER ET AL.: "A human transmembrane protein-tyrosine-phosphatase gamma, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 89, no. 16, 15 August 1992 (1992-08-15), WASHINGTON US, pages 7417 - 7421, XP002027168 *
See also references of WO9409037A1 *

Also Published As

Publication number Publication date
AU5443394A (en) 1994-05-09
NZ257713A (en) 1996-10-28
EP0677063A1 (fr) 1995-10-18
WO1994009037A1 (fr) 1994-04-28
CA2147167A1 (fr) 1994-04-28
JPH08502487A (ja) 1996-03-19

Similar Documents

Publication Publication Date Title
DE69735647D1 (de) Kondensierte pyrrolcarboxamide; eine neue klasse von gabe-gehirn-rezeptoren-liganden
DE3580705D1 (de) Fluessigkristallesterverbindungen und ihre mischungen.
ATE239002T1 (de) Einige amido-und amino-substituierte benzylaminderivate: eine neue klasse von neuropeptid y1 spezifischen liganden
AR241011A1 (es) "un metodo de fundir y refinar material vitreo o lo similar".
DE19781673T1 (de) Rückgewinnung von Wertmetallgehalten
DE69126990D1 (de) Giessen von metallgegenständen
DE69020196D1 (de) Reissverschluss und Kuppelglied dafür.
DE3673000D1 (de) Aether-isonitrile und ihre radiomarkierten komplexe.
ITRM940706A0 (it) "isochinoline"
DE69529700D1 (de) Neue Klasse von hochenergetischen Detektionsmaterialien
DE59507427D1 (de) Mischkristalle und feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE3873797D1 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE69303756D1 (de) Artikel zum Aufnehmen und Zurückgewinnen von Flüssigkeiten
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE69221099D1 (de) Mischungen von Dispersionsfarbstoffen
ATE114406T1 (de) Konzentrierte wässerige lösung von glutaraldehyd und 1,2-benzisothiazolin-3-on.
DE3772315D1 (de) N-tetrazolyl-thiazolcarboxamid-derivate und ihre anwendung.
DE59309337D1 (de) Feste und flüssige Lösungen von Flavonoiden
EP0677063A4 (fr) NOUVELLE CLASSE DE RPTPases: LEURS DOMAINES STRUCTURAUX ET LIGANDS.
DE69421273D1 (de) Kristallisation von 2,6-dimethylnaphthalin
DE69015297D1 (de) Thermische Behandlung von schweren Erdölen.
ATE78984T1 (de) Rueckgewinnung und uebertragung von aroma.
DE69522582D1 (de) NEUE VERWENDUNGEN VON INDOLO-[2,3b]-CHINOXALINEN
DE3773256D1 (de) Fluessige filmbeschichtung von metallen auf eisenbasis.
DE69407766D1 (de) Oxidation von ketonen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19970407

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990501